Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY
ODYSSEY
1 other identifier
observational
300
1 country
8
Brief Summary
Previous investigations have demonstrated the agreement between OdySight® and standardised methods in the evaluation of near visual acuity. The app allows for remote monitoring of this parameter with tracking changes. In case of decrease in visual acuity, a notification is sent to both patient and ophthalmologist. The aim of this study is to evaluate the medical relevance of OdySight® features in the management of patients suffering from impaired visual acuity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2023
CompletedFirst Submitted
Initial submission to the registry
October 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedNovember 7, 2023
November 1, 2023
11 months
October 4, 2023
November 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of OdySight® in the management of patients suffering from impaired visual acuity.
Number of patients concerned by one or more OdySight® notification(s) for visual acuity decrease followed by a visit where at least one of the following situations is noticed: * Visual acuity decrease * Anatomic ophthalmic deterioration * Prescription impact * Second eye newly affected and/or development of the pathology to the second eye
At least 3 months of follow-up.
Secondary Outcomes (1)
Performances of OdySight® in tracking visual acuity decrease and/or anatomic change.
At least 3 months of follow-up.
Study Arms (1)
OdySight users
OdySight users between 07/21/2021 and 11/14/2022 who performed Visual Acuity testing through OdySight and according to standard practice.
Interventions
Eligibility Criteria
Subjects with a near visual acuity between 0.0 and 1.0 logMAR in at least one eye, and binocular VA equal to or better than 0.5 logMAR are targeted for this study.
You may qualify if:
- OdySight® user (between 07/21/2021 and 11/14/2022),
- Performed at least 3 tests on the same eye (minimum number of tests to trigger an alert).
You may not qualify if:
- Opposition to personal data collection and processing,
- Patient's death is documented.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tilak Healthcarelead
Study Sites (8)
Centre Ophtalmologique Oculus
Chambéry, Auvergne-Rhône-Alpes, 73000, France
Centre Ophtalmologique Rabelais
Lyon, Auvergne-Rhône-Alpes, 69002, France
SELARL Dr Boulet
Évreux, Normandy, 27000, France
Clinique Mathilde
Rouen, Normandy, 76000, France
Clinique Honoré Cave
Montauban, Occitanie, 82000, France
Institut Ophtalmologique de l'Ouest Jules Verne
Nantes, Pays de la Loire Region, 44300, France
Institut ophtalmologique Sourdille Atlantique
Saint-Herblain, Pays de la Loire Region, 44800, France
Hôpital des XV-XX
Paris, Île-de-France Region, 75012, France
Related Publications (12)
GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
PMID: 33275949BACKGROUNDClaessens JLJ, Geuvers JR, Imhof SM, Wisse RPL. Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review. Ophthalmol Ther. 2021 Dec;10(4):715-730. doi: 10.1007/s40123-021-00360-3. Epub 2021 Jun 25.
PMID: 34169468BACKGROUNDSrinivasan K, Ramesh SV, Babu N, Sanker N, Ray A, Karuna SM. Efficacy of a remote based computerised visual acuity measurement. Br J Ophthalmol. 2012 Jul;96(7):987-90. doi: 10.1136/bjophthalmol-2012-301751. Epub 2012 Apr 26.
PMID: 22539747BACKGROUNDYeung WK, Dawes P, Pye A, Neil M, Aslam T, Dickinson C, Leroi I. eHealth tools for the self-testing of visual acuity: a scoping review. NPJ Digit Med. 2019 Aug 22;2:82. doi: 10.1038/s41746-019-0154-5. eCollection 2019.
PMID: 31453377BACKGROUNDWilliams AM, Kalra G, Commiskey PW, Bowers EMR, Rudolph BR, Pitcher MD, Dansingani KK, Jhanji V, Nischal KK, Sahel JA, Waxman EL, Fu R. Ophthalmology Practice During the Coronavirus Disease 2019 Pandemic: The University of Pittsburgh Experience in Promoting Clinic Safety and Embracing Video Visits. Ophthalmol Ther. 2020 Sep;9(3):1-9. doi: 10.1007/s40123-020-00255-9. Epub 2020 May 6.
PMID: 32377502BACKGROUNDTiraset N, Poonyathalang A, Padungkiatsagul T, Deeyai M, Vichitkunakorn P, Vanikieti K. Comparison of Visual Acuity Measurement Using Three Methods: Standard ETDRS Chart, Near Chart and a Smartphone-Based Eye Chart Application. Clin Ophthalmol. 2021 Feb 26;15:859-869. doi: 10.2147/OPTH.S304272. eCollection 2021.
PMID: 33664563BACKGROUNDMiller JM, Jang HS, Ramesh D, Gonzalez Marshall MS, Yescas S, Harvey EM. Telemedicine distance and near visual acuity tests for adults and children. J AAPOS. 2020 Aug;24(4):235-236. doi: 10.1016/j.jaapos.2020.06.003. Epub 2020 Jul 30.
PMID: 32739362BACKGROUNDIskander M, Hu G, Sood S, Heilenbach N, Sanchez V, Ogunsola T, Chen D, Elgin C, Patel V, Wronka A, Al-Aswad LA. Validation of the New York University Langone Eye Test Application, a Smartphone-Based Visual Acuity Test. Ophthalmol Sci. 2022 Jun 15;2(3):100182. doi: 10.1016/j.xops.2022.100182. eCollection 2022 Sep.
PMID: 36245756BACKGROUNDKielwasser G, Kodjikian L, Dot C, Burillon C, Denis P, Mathis T. Real-Life Value of the Odysight(R) Application in At-Home Screening for Exudative Recurrence of Macular Edema. J Clin Med. 2022 Aug 26;11(17):5010. doi: 10.3390/jcm11175010.
PMID: 36078941BACKGROUNDGuigou S, Michel T, Merite PY, Coupier L, Meyer F. Home vision monitoring in patients with maculopathy: Real-life study of the OdySight application. J Fr Ophtalmol. 2021 Jun;44(6):873-881. doi: 10.1016/j.jfo.2020.09.034. Epub 2021 May 20.
PMID: 34024655BACKGROUNDBrucker J, Bhatia V, Sahel JA, Girmens JF, Mohand-Said S. Odysight: A Mobile Medical Application Designed for Remote Monitoring-A Prospective Study Comparison with Standard Clinical Eye Tests. Ophthalmol Ther. 2019 Sep;8(3):461-476. doi: 10.1007/s40123-019-0203-9. Epub 2019 Jul 25.
PMID: 31346977BACKGROUNDAllen L, Thirunavukarasu AJ, Podgorski S, Mullinger D. Novel web application for self-assessment of distance visual acuity to support remote consultation: a real-world validation study in children. BMJ Open Ophthalmol. 2021 Sep 30;6(1):e000801. doi: 10.1136/bmjophth-2021-000801. eCollection 2021.
PMID: 34651083BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Bénédicte BROUSSEAU, MD
Centre Ophtalmologique Ophtalliance
- PRINCIPAL INVESTIGATOR
Maddalena QUARANTA, MD
Centre Ophtalmologique Rabelais
- PRINCIPAL INVESTIGATOR
Vincent GUALINO, MD
Clinique Honoré Cave
- PRINCIPAL INVESTIGATOR
Jean-François GIRMENS, MD
Hopital des XV-XX
- PRINCIPAL INVESTIGATOR
Isabelle FOURNIER, MD
Institut ophtalmologique Sourdille Atlantique
- PRINCIPAL INVESTIGATOR
Marie-Noëlle GUILLEMOT, MD
Institut ophtalmologique Sourdille Atlantique
- PRINCIPAL INVESTIGATOR
Jean-François BOULET, MD
Cabinet d'ophtalmologie
- PRINCIPAL INVESTIGATOR
Pierre-Olivier LAFONTAINE, MD
Centre Ophtalmologique Oculus
- PRINCIPAL INVESTIGATOR
Joël UZZAN, MD
Clinique Mathilde
- PRINCIPAL INVESTIGATOR
Viviane VINH, MD
Centre d'Ophtalmologie du Dauphiné
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2023
First Posted
October 11, 2023
Study Start
January 27, 2023
Primary Completion
December 31, 2023
Study Completion
January 31, 2024
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share